Changes of a Cerebral Cavernous Malformation Associated With Lecanemab Therapy in a Patient With Alzheimer Disease
{{output}}
Background and objectives: Antiamyloid immunotherapies are associated with increased risk of intracerebral hemorrhage, particularly in the setting of APOE-ε4 carriership, anticoagulation, thrombolytics, and other lesions at risk... ...
